摘要
引言藥品是事關公家健康乃至生命安全的特殊商品,各國對其上市銷售均設置了嚴格的審評審批程序。與此同時,在中國,醫院探購藥品使得病患能够通過醫生開具的處方從醫院購買藥品,是藥品銷售的最主要渠道1。藥品獲得上市審批後要通過醫院渠道進行銷售,還需要經過諸如申請進入醫保目錄、掛網、参加招標探購等一系列程序,這些行為均發生在醫院實際探購藥品(即藥品銷售行為)之前,更在病患獲得藥品之前。
Introduction Drugs are special commodities that play an important role inpublic health and even life safety.All countries set stringent review and approval procedures for theirmarketing.Meanwhile,in China,drug procurement by hospitals,which enables patients to get medications they need based on the doctors'prescriptions,is the most important channel for pharmaceutical sales.1 Before the sale of approved drugs within hospitals,drugs are required to go through a series of procedures,such as application for entry into the medical insurance drug catalogue,network bidding and procurement tendering,all of which occur before the actual drug procurement by hospitals(namely,the sale of drugs),and surely before the purchase of drugs by patients.In the light of relevant provisions of the patent law,patent exploitation refers to the exclusive right to make,use,offer to sell,sellor import a patent.
作者
程永順
吴莉娟
Cheng Yongshun;Wu Lijuan(Beijing Intellectual Property Institute)
出处
《中国专利与商标》
2022年第4期17-30,共14页
China Patents & Trademarks